遗传变异HLA-DQB1与对宫癌的保护作用有关
Michael A Vinokurov1, Konstantin O Mironov1, Elvira A Domonova1
1Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia.
Frontiers in oncology
|August 24, 2023
概括
遗传倾向对子宫癌 (CC) 的发展起着重要作用. 在HR-HPV阳性女性中,HLA-DQB1中的rs55986091-A等位基因表现出对CC和高度宫内皮瘤 (CIN) 的保护作用.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 病毒学 病毒学
背景情况:
- 子宫癌 (CC) 是一个重要的全球健康问题,主要是由高风险的人类乳头瘤病毒 (HR-HPV) 引起的.
- 并非所有HR-HPV感染都会导致CC,这表明遗传因素在疾病发展中的作用.
- 了解遗传倾向对于识别高风险女性至关重要.
研究的目的:
- 研究特定遗传变异 (SNP) 与患子宫癌的风险之间的关联.
- 分析这些遗传风险的分布,与HR-HPV状态和宫病进展有关.
- 为了确定宫癌风险分层的潜在遗传标记.
主要方法:
- 这是一项涉及四组女性的比较研究:HPV阴性女性,HPV阳性女性,CIN 2/3级女性和CC女性.
- 对四种单核酸多态 (SNP) 的基因型分析:rs55986091 (HLA-DQB1),rs138446575 (TTC34),rs1048943 (CYP1A1) 和rs2910164 (miRNA-146a).
- 使用逻辑加法模型进行统计分析,以确定赔率比率 (OR) 和置信区间 (CI).
主要成果:
- 与HPV阴性个体相比,HLA-DQB1中的rs55986091-A基因基因基因表现出显著的防护作用,可以预防CC (OR=0.4,95%CI=0.25-0.65).
- 在CIN 2/3 (OR=0.47,95% CI=0.28-0.79) 的女性中观察到rs55986091-A等位基因具有类似的保护作用.
- 在CC或CIN的背景下,对其他分析的SNP没有报告显著的保护或风险影响.
结论:
- 在HR-HPV阳性女性中,rs55986091-A等位基因与患子宫癌和高度CIN风险降低有关.
- 这些发现凸显了基因分析对于个性化风险评估在宫癌预防中的重要性.
- 为俄罗斯人口推开发基于PCR的诊断套件,用于rs55986091等位基的鉴定.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K


